Properties
Description
Vandetanib trifluoroacetate is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells. It targets EGFR/HER1, VEGFR2, and VEGFR3.
Molecular Formula
C24H25BrF4N4O4
Targets
EGFR/HER1: 500 nM; VEGFR2: 40 nM; VEGFR3: 110 nM
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Vandetanib trifluoroacetate is used to research its dual inhibition of VEGFR and EGFR in cancer treatment.